SynthesisFrontiers in nutrition2026
Acute caffeine intervention and cognitive performance in populations aged 20 years and younger: a systematic review and meta-analysis.
Synthesis in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This systematic review and meta-analysis aimed to evaluate the acute effects of caffeine supplementation on cognitive performance in healthy populations aged 20 years and younger, and to explore potential moderators including dose, cognitive domain, population type, and outcome measure. Methods: Four databases (Web of Science, PubMed, MEDLINE, and Cochrane Library) were searched from inception to March 2026. Randomized controlled trials and randomized crossover trials assessing the effects of acute oral caffeine versus placebo on cognitive outcomes in individuals aged ≤20 years were included. A two-level meta-analytic model was used to calculate pooled standardized mean differences (SMD). Subgroup analyses and meta-regression were performed to explore potential methodological moderators influencing the overall effect. Results: Fourteen studies comprising 250 participants and 37 effect sizes were included. Caffeine demonstrated a small positive effect on cognitive task performance compared with placebo (SMD = 0.41, 95% CI 0.28-0.55; Conclusion: Among individuals aged 20 and younger, acute caffeine ingestion produces a small yet statistically significant beneficial effect on cognitive performance. Specifically, moderate improvements were observed in psychomotor speed and attention, alongside smaller gains in executive function. No significant moderators influencing this ergogenic effect were identified in the present meta-analysis. Importantly, the conclusion that habitual caffeine intake exerts no moderating impact is derived from only seven studies and may be limited by insufficient statistical power. These findings offer tentative support for the judicious use of caffeine to boost cognition among young athletes and healthy adolescents, yet caution is warranted given the small number of small-sample studies. Systematic review registration: This systematic review has been registered in PROSPERO (International Prospective Register of Systematic Reviews) under registration number CRD420261342996.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.